17 Mar 2026 · In person · Dr. Ulrich Zimmermann, Cleveland Clinic · MSL Mei Tanaka · Vantrexa
No questions recorded.
Advisory board with radiation oncologist at Cleveland Clinic. Discussed chemotherapy-free first line, pd-l1 testing turnaround.
No insights captured from this engagement.
Review complete. Quality ratings and insights can now be used in aggregates.
No follow-ups recorded.
1–5, rated at review
All create, update and approval events for this record
No audit events in sample data